[
    "This phase 1 trial is testing the drug AP23573 on patients with malignant glioma, glioblastoma, or gliosarcoma who have failed standard therapy and meet specific eligibility criteria.",
    "The sample is a phase 1/phase 2 trial for the treatment of schizophrenia using dronabinol, with inclusion criteria including chronic cannabis use and current antipsychotic medication, and exclusion criteria including use of illicit drugs other than cannabis and taking clozapine.",
    "The sample is a phase 1 trial for patients with metastatic melanoma who have received prior Melan-A peptide vaccine and achieved a detectable immune response, and the trial will test the efficacy of cyclophosphamide and fludarabine phosphate as treatment options.",
    "This phase 1 trial is testing the efficacy of mm-121, irinotecan, and cetuximab on various cancers, including colorectal, head and neck, lung, and triple negative breast cancer, in patients who have exhausted standard treatment options and meet certain eligibility criteria.",
    "This phase 1 trial is testing the efficacy of bortezomib and ganciclovir in treating Epstein Barr virus-positive lymphoma, including subtypes such as Burkitt's lymphoma and Hodgkin's lymphoma, in patients who are unresponsive to or have relapsed after at least one prior chemotherapy regimen, and meet a range of eligibility criteria.",
    "This trial is testing the efficacy of FX005, a drug, versus two placebos in treating osteoarthritis of the knee in patients who meet specific inclusion and exclusion criteria.",
    "The sample is a phase 1 trial testing the combination of vorinostat and docetaxel in patients with non-small-cell lung carcinoma, prostate cancer, bladder cancer, or urothelial carcinoma that has progressed after chemotherapy or hormone therapy, with specific inclusion and exclusion criteria.",
    "This trial is testing the efficacy of erlotinib hydrochloride and hsp90 inhibitor auy922 in patients with advanced lung adenocarcinoma who have previously responded to EGFR-TKI or have a documented mutation in the EGFR gene, and have met certain eligibility criteria.",
    "The sample is a phase 1 trial for the treatment of chronic hepatitis C with drugs PPI-668 and placebo, with eligibility criteria including age, BMI, health status, and exclusion criteria including HIV or HBV infection, medical conditions that may interfere with the study, and history of alcohol or drug abuse.",
    "This trial is testing the effectiveness of panitumumab, epirubicin, oxaliplatin, and xeloda in treating esophageal and gastric adenocarcinoma, with specific eligibility criteria and exclusion criteria listed.",
    "The sample is a phase 1/phase 2 trial for patients with diffuse large cell B-cell NHL who have failed prior systemic chemotherapy with or without monoclonal antibody-based therapies, testing the drug clofarabine, with specific inclusion and exclusion criteria.",
    "The sample is a phase 1/phase 2 trial for patients with unresectable metastatic germ cell cancer, using a combination of cisplatin, gemcitabine hydrochloride, ifosfamide, and paclitaxel, with specific eligibility criteria including rising serum markers and no prior allergic reactions to cisplatin or other platinum compounds.",
    "This trial is testing the efficacy of fulvestrant, mk-0646, and dasatinib in treating metastatic hormone receptor-positive HER2-negative breast cancer in postmenopausal patients who have received up to one line of endocrine therapy, and require easily accessible tumors for biopsy.",
    "This phase 1 trial is testing the efficacy of capecitabine and gemcitabine hydrochloride in treating locally advanced adenocarcinoma of the pancreas, with eligibility criteria including Zubrod performance status 0-1, no prior systemic chemotherapy for pancreatic cancer, and no prior allergic reaction to the drugs.",
    "The sample is a phase 1 trial testing the drug azd2171 on patients with advanced cancer and hepatic impairment, with inclusion criteria including written informed consent, WHO performance status 0-2, and bilirubin levels within the target range, and exclusion criteria including unstable brain/meningeal metastases, inadequate bone marrow reserve, biochemistry/haematology results outside of required ranges, and history of significant GI impairment.",
    "This phase 1 trial is testing the efficacy of paliperidone palmitate, a drug used to treat schizophrenia, on participants who meet specific inclusion criteria, including having a PANSS score of less than or equal to 4 and having experience taking a risperidone or paliperidone formulation.",
    "The sample is a phase 1/2 clinical trial for haploidentical stem cell transplantation in patients with various types of leukemia, lymphoma, and myelodysplastic syndrome, using a conditioning regimen and a list of drugs including regulatory T-cells, conventional T-cells, melphalan, thiotepa, and anti-thymocyte globulin, with specific eligibility criteria for both recipient and donor.",
    "The sample is a phase 1/phase 2 trial testing docetaxel and oxaliplatin in patients with adenocarcinoma of gastric-esophagal junction, with a list of diseases and icd-10 codes, and eligibility criteria including stage II to III and unidimensional measurable disease.",
    "The sample is a phase 1/phase 2 trial for sickle cell disease and pulmonary hypertension, testing the effectiveness of hydroxyurea, with specific eligibility criteria and exclusion criteria.",
    "This phase 1 trial is testing the efficacy of faster-acting insulin aspart and insulin aspart in patients with type 1 diabetes mellitus who have been using a MiniMed Paradigm pump for the previous 6 months, with specific inclusion and exclusion criteria. The trial is focused on patients with diabetes and the drugs being tested.",
    "This trial is testing the combination of F16IL2 and doxorubicin for patients with advanced solid tumors or breast cancer, with specific eligibility criteria including previous anthracycline therapy and certain hematologic, liver, and renal function requirements.",
    "This trial is for patients with non-small-cell lung carcinoma who have previously been treated with at least one platinum-based chemotherapy, and will test the efficacy of a study treatment drug, with eligibility criteria including a performance status of 0-2, adequate hematologic, hepatic, and renal function, and informed consent from the patient or their relative.",
    "This trial is a phase 1/phase 2 study for end stage renal disease and renal transplant patients, testing the efficacy of anti-thymocyte globulin, tol101, steroids, tacrolimus, and mycophenolate mofetil (mmf) as immunosuppressive drugs, with specific inclusion and exclusion criteria.",
    "This trial is testing the efficacy of RAD001, cetuximab, cisplatin, and carboplatin in treating patients with recurrent or metastatic squamous cell carcinoma of the head and neck, with specific eligibility criteria for patients, including normal organ and marrow function and ability to receive enteral nutrition.",
    "This clinical trial is testing the effectiveness of paclitaxel, a chemotherapy drug, on patients with advanced or metastatic solid cancer who have failed standard therapy, and have met certain eligibility criteria.",
    "The sample is a phase 1/2 clinical trial for patients with multiple myeloma and plasma cell neoplasm, testing the efficacy of bortezomib, melphalan, and pegylated liposomal doxorubicin hydrochloride, with eligibility criteria including prior therapeutic regimens and specific patient characteristics.",
    "This phase 1 trial is testing a vaccine for HIV in healthy participants who meet specific eligibility criteria, including age, medical history, and laboratory results.",
    "This trial is testing the efficacy of xl147, xl765, and letrozole in treating ER+ and/or PGR+ breast cancer that is negative for HER2 and refractory to nonsteroidal aromatase inhibitors, with eligibility criteria including postmenopausal females with adequate organ and marrow function and exclusion criteria including prior treatment with a selective inhibitor of PI3K, AKT, and/or mTOR and uncontrolled significant intercurrent illness.",
    "The sample is a phase 1 trial for head and neck cancer using zd6474 (vandetanib) and cisplatin as drugs, with inclusion criteria of stage III-IV squamous cell carcinoma of the head and neck and exclusion criteria of no previous treatment for head and neck cancer and adequate cardiac function.",
    "The sample is a phase 1/phase 2 trial for urinary incontinence, testing the drugs uish001 and matching placebo, with inclusion criteria of moderate to severe urge, stress or mixed urinary incontinence and exclusion criteria of certain medical histories and conditions that would interfere with subject safety.",
    "This phase 1 clinical trial is testing the efficacy of dasatinib, a drug used to treat leukemia, on children and young adults with Ph-positive or Ph-negative acute leukemia, with specific eligibility criteria and exclusion criteria.",
    "The sample is a phase 1/phase 2 trial for postmenopausal women with breast cancer and bone diseases, testing the eligibility and efficacy of adjuvant therapy with vitamin D, with specific inclusion and exclusion criteria.",
    "This trial is testing the efficacy of erlotinib with cetuximab in treating lung adenocarcinoma patients who have received treatment with erlotinib for >3 months and have a documented mutation in EGFR exons 19 or 21, with inclusion and exclusion criteria specified.",
    "This phase 1 trial is testing the combination of sunitinib malate and rapamycin in patients with metastatic or unresectable tumors, with eligibility criteria including measurable disease, ECOG performance status of 0-1, and normal cardiac ejection fraction.",
    "This phase 1 trial is testing the combination of gemcitabine and dasatinib in patients with refractory solid tumors and pancreatic adenocarcinoma, with specific eligibility criteria for dose escalation and expansion phases, and exclusion criteria including certain medical conditions and medications.",
    "This is a phase 1/phase 2 trial for XOMA 052 and placebo in patients with type 2 diabetes, with eligibility criteria including stable disease, HbA1c between 7.5% and 12%, and exclusion criteria including recent changes in diabetes medication and use of certain medications.",
    "This phase 1 trial is testing the drug sjg-136 on patients with metastatic or unresectable solid tumor malignancy, with eligibility criteria including prior chemotherapy or immunotherapy, ECOG performance status =<2, and various blood count and organ function requirements.",
    "This phase 1 trial is testing the efficacy of leuprolide acetate, goserelin acetate, bicalutamide, nilutamide, flutamide, and temsirolimus in treating patients with adenocarcinoma of the prostate recurring after local therapy, with specific eligibility criteria including PSA doubling time and absence of metastasis.",
    "The sample is a phase 1 trial for newly diagnosed operable breast cancer patients with HER2 positive disease, testing the efficacy of paclitaxel, gemcitabine, and lapatinib, with eligibility criteria including clinical stage II or III operable breast cancer, axillary node positivity, and no prior hormonal, chemotherapy, or radiotherapy.",
    "This phase 1 trial is testing cytarabine as a treatment for various types of adult acute myeloid leukemia, with specific eligibility criteria including ECOG status 0-2 and normal liver and kidney function.",
    "The sample is a phase 1 trial for patients with advanced solid tumors, testing the effectiveness of tas-102 and trifluridine drugs, with eligibility criteria including ECOG performance status of 0 or 1 and adequate organ function, and exclusion criteria including recent treatment with anticancer therapy or investigational agents, certain serious illnesses or medical conditions, and unresolved toxicity of prior therapies.",
    "This is a phase 1 trial for diabetes using metformin as the drug, with inclusion criteria of male and female subjects aged 35-55 with no known history of diabetes, and exclusion criteria of pregnant women, subjects with major illnesses, and transferable jobs.",
    "This phase 1 trial is testing the safety of a placebo in healthy adults with hepatitis C, with strict eligibility criteria including negative HCV RNA and cryoglobulin, and exclusion criteria such as diabetes, cancer, and autoimmune disease.",
    "The sample is a clinical trial for relapsing remitting multiple sclerosis, testing the efficacy of mycophenolate mofetil and human interferon beta 1a, with specific inclusion and exclusion criteria.",
    "This trial is testing the effectiveness of panitumumab and conatumumab in treating metastatic colorectal cancer, with eligibility criteria including prior chemotherapy regimens and specific hematologic, renal, and hepatic function limits.",
    "The sample is a phase 1/phase 2 trial for patients with renal cell carcinoma, testing the efficacy of ril-21 alone or in combination with sorafenib, with specific inclusion and exclusion criteria.",
    "This phase 1 trial is testing the drug bibf 1120 on patients with advanced solid tumors who have completed a previous study with the drug, and have met certain eligibility criteria and exclusion criteria.",
    "This early phase 1 trial aims to test the efficacy of topiramate and phenytoin in treating traumatic brain injury and epilepsy, with specific inclusion and exclusion criteria, and the use of ICD-10 codes to identify the diseases.",
    "The sample is a phase 1/phase 2 trial testing a vaccine enhancement patch for A/H5N1 influenza in healthy adults, with inclusion and exclusion criteria listed, and no diseases other than \"healthy\" mentioned.",
    "The sample is a phase 1 trial for patients with colon cancer and cancer, testing the effectiveness of resveratrol, with inclusion criteria including a plan for surgical resection at UCIMC within 2-4 weeks of enrollment and exclusion criteria including patients under 18 years of age.",
    "This phase 1 trial is testing the efficacy of Osi-906 and Everolimus in treating metastatic colorectal cancer patients who have progressed on or are intolerant to other treatments, with specific eligibility criteria including Kras mutation testing and adequate hematological function.",
    "The sample is a phase 1/phase 2 trial for locally advanced and non-metastatic rectal adenocarcinoma, testing the efficacy of the drugs s-1 and oxaliplatin, with inclusion and exclusion criteria listed.",
    "The sample is a phase 1/phase 2 trial testing the use of levonorgestrel as a contraceptive method in healthy women, with a list of inclusion and exclusion criteria, including medical conditions and medications that may interfere with the efficacy of the contraceptive.",
    "The sample is a phase 1 trial testing the drug bms-690514 on patients with solid tumors, with specific inclusion and exclusion criteria, and the diseases are cancer and tumor with corresponding icd-10 codes.",
    "The sample is a phase 1 trial for patients with acute coronary syndromes, testing the use of clopidogrel and prasugrel as thienopyridine drugs, with specific inclusion and exclusion criteria listed.",
    "This phase 1 trial is testing the efficacy of oratecan and capecitabine in treating advanced solid tumors with specific eligibility criteria, including a life expectancy greater than 12 weeks and adequate bone marrow, renal, and liver function.",
    "This phase 1 trial is testing the safety of LY2603618, pemetrexed, and gemcitabine in treating advanced cancer patients who have exhausted standard therapies, with eligibility criteria including adequate hematologic, hepatic and renal function, and a performance status of less than or equal to 2 on the Eastern Cooperative Oncology Group (ECOG) scale.",
    "This phase 1 trial is testing the effectiveness of thalidomide in treating endometriosis in patients who have failed standard treatment modalities and meet specific inclusion criteria.",
    "The sample is a phase 1 trial for patients with metastatic or unresectable malignant solid tumors, testing the efficacy of irinotecan hydrochloride and thalidomide, with eligibility criteria including measurable or assessable disease, performance status, and various medical parameters.",
    "The sample is a phase 1 trial testing the drug GFT505 in healthy volunteers and type 2 diabetic patients with various diseases including type 2 diabetes, metabolic diseases, and cardiovascular diseases, and the eligibility criteria includes BMI, blood pressure, and medication history.",
    "This phase 1 trial is testing the efficacy of topotecan and RAD001 in treating advanced or recurrent endometrial cancer patients who are refractory to standard therapy, with eligibility criteria including adequate bone marrow and liver function, and exclusion criteria including prior treatment with an mTOR inhibitor and uncontrolled medical conditions.",
    "The sample is a phase 1 trial for a drug called gw642444h and its variants, being tested on patients with stable mild to moderate asthma who are non-smokers and taking daily doses of inhaled fluticasone propionate, with inclusion and exclusion criteria listed, and the diseases being tested are pulmonary disease, chronic obstructive.",
    "The sample is a phase 1 trial for patients with metastatic or inoperable malignant solid tumors, testing the drug talotrexin ammonium, with eligibility criteria including ECOG 0-2 performance status, no prior bone marrow transplantation, and recovered from prior therapy.",
    "The sample is a phase 1/phase 2 trial for Hodgkin's disease, testing the efficacy of prednisone, vinblastine, doxorubicin, and gemcitabine, with specific eligibility criteria including clinical stage and age range.",
    "This trial is for patients with high-risk hematologic or oncologic diagnoses who have already undergone front-line therapy and are eligible for allogeneic HSCT, with inclusion criteria including having a related donor with at least a 4 antigen match and adequate organ function, and the use of drugs fludarabine, thiotepa, and melphalan, while exclusion criteria include HIV positivity, active involvement of the central nervous system with malignancy, and inability to obtain informed consent.",
    "The sample is a phase 1 trial for depression, testing the drugs azd6765, ketamine, and placebo, with inclusion criteria of major depressive disorder and exclusion criteria of certain psychiatric disorders and use of certain drugs.",
    "This phase 1 trial is testing the efficacy of clofarabine, a drug, in treating myelodysplastic syndrome, a disease, in patients who meet certain eligibility criteria.",
    "This phase 1 trial is testing the efficacy of amg 157 and its matching placebo on mild atopic asthma patients with a positive skin prick test to common aeroallergens, and the eligibility criteria includes BMI between 18 and 35 kg/m2, no current exposure to allergens to which subject experiences asthmatic responses, and no other lung disease, exacerbations of asthma or lower respiratory tract infections for at least 6 weeks prior to screening.",
    "The sample is a phase 1/phase 2 trial for non-small cell lung cancer, testing the efficacy of pemetrexed and cisplatin, with eligibility criteria including age, diagnosis, and adequate organ function, and exclusion criteria including previous chemotherapy or thoracic radiation therapy, and unsuitability for the study.",
    "The sample is a phase 1/phase 2 trial for the treatment of moderate to severe plaque psoriasis using adalimumab, with eligibility criteria including negative pregnancy test, no active or latent tuberculosis, and willingness to self-administer subcutaneous injections or have a qualified person available to administer these injections.",
    "The sample is a phase 1 clinical trial for atopic dermatitis, testing the efficacy of placebo and dupilumab drugs on patients who meet specific eligibility criteria and exclusion criteria.",
    "This trial is testing the efficacy of d-methadone and placebo in treating chronic pain in patients with various types of cancer, with specific inclusion and exclusion criteria, and divided into Phase I and Phase II portions.",
    "The sample is a phase 1 trial testing the drug cnto 136 on patients with cutaneous or systemic lupus erythematosus, with inclusion and exclusion criteria specified, and the drug being compared to a placebo.",
    "The sample is a phase 1 clinical trial for kidney transplant recipients testing the effectiveness of sirolimus, with inclusion criteria including age over 18 and negative pregnancy test for females, and diseases including kidney diseases with icd-10 codes I12.9, N18.9, Q61.9, I12.0, D63.1, N18.1, N18.5.",
    "The sample is a phase 1/phase 2 trial for patients with multiple myeloma, testing the efficacy of doxil, melphalan, and bortezomib, with eligibility criteria including previous diagnosis of multiple myeloma, progressive disease, and ECOG Performance Status 0-2.",
    "The sample is a phase 1 trial for the drug inno-105 in patients with solid tumors, with inclusion and exclusion criteria listed.",
    "The sample is a phase 1/phase 2 clinical trial for patients with advanced stage IV non-small cell lung cancer, testing the drug abi-007, with eligibility criteria including no prior chemotherapies for metastatic disease, expected survival of greater than 12 weeks, and ECOG performance status 0-1.",
    "The sample is a phase 1/phase 2 trial for advanced germ cell tumors, including brain and central nervous system tumors, using carboplatin, ifosfamide, and paclitaxel, with eligibility criteria including measurable disease or elevated tumor markers, platelet count \u2265 100,000/mm^3, and negative serology for various infections.",
    "The sample is a phase 1 trial for chronic obstructive pulmonary disease (COPD) testing the drugs pf-03715455 and ph-797804, along with placebos, with inclusion criteria including age, lung function, and normoresponsive airways, and exclusion criteria including certain medical histories and recent infections.",
    "The sample is a phase 1 trial testing the drug ly2608204 on patients with type 2 diabetes mellitus who are currently treated with diet/lifestyle measures alone or in combination with anti-diabetic agents, including insulins, and have specific eligibility criteria.",
    "This phase 1 trial is testing the efficacy of LY2409021 and placebo in treating type 2 diabetes in patients with specific eligibility criteria, including a stable HbA1c value and BMI, and excluding those with certain medical conditions or taking certain medications.",
    "This clinical trial is testing the use of sorafenib for patients with unresectable hepatocellular carcinoma who meet specific eligibility criteria.",
    "The sample is a phase 1 trial for healthy adults, testing the effects of olanzapine and zyprexa tablets, with inclusion criteria of being able to swallow medication and exclusion criteria of having any significant disease or recent use of prescription or OTC medications.",
    "The sample is a phase 1 trial for healthy volunteers testing the effects of glycopyrrolate inhalation, with inclusion and exclusion criteria listed.",
    "The sample is a phase 1/phase 2 trial for postural orthostatic tachycardia syndrome and orthostatic intolerance, testing the effectiveness of droxidopa, atenolol, and placebos, with eligibility criteria including CDC criteria for chronic fatigue syndrome and evidence of postural tachycardia syndrome with symptoms of orthostatic intolerance.",
    "This is a phase 1 trial for liver cancer and cholangiocarcinoma patients, testing the drug bevacizumab, with eligibility criteria including prior treatments, performance status, and lab values.",
    "This phase 1 trial is testing the drug LX4211 and its placebo on adults with type 2 diabetes mellitus and moderate to severe renal impairment who are willing and able to perform self-monitoring of blood glucose, with a list of inclusion and exclusion criteria.",
    "The sample is a phase 1 trial for patients with type 2 diabetes mellitus, testing the efficacy of pf-04991532 and placebo drugs, with eligibility criteria including BMI, HbA1c levels, and exclusion criteria including history of diabetic complications, stroke, and myocardial infarction.",
    "This clinical trial is for a phase 1 study of gamma-secretase/notch signalling pathway inhibitor ro4929097 for patients with various metastatic cancers to the brain, including estrogen receptor-negative breast cancer, extensive stage small cell lung cancer, and recurrent melanoma, among others. The eligibility criteria include measurable disease in the brain, Karnofsky performance status >= 70%, and the ability to swallow pills.",
    "This phase 1 trial is testing the safety and efficacy of gs-9669 tablets and placebo in treating chronic hepatitis C in adults, with specific inclusion and exclusion criteria.",
    "The sample is a phase 1 trial testing ly2409021, placebo, and glucagon on patients with type 1 diabetes mellitus, with inclusion criteria including a daily insulin dose \u22641.5 IU/kg, HbA1c \u22649.0%, and BMI between 19.0 and 35.0 kg/m^2, and exclusion criteria including recent use of diabetes medication, severe hypoglycemia, pregnancy, liver or kidney disease, and other conditions that could increase risk for hypoglycemia.",
    "The sample is a phase 1/phase 2 trial for rheumatoid arthritis testing the efficacy of abatacept or placebo, with specific inclusion and exclusion criteria for participants.",
    "The sample is a phase 1/phase 2 trial for patients with hematologic malignancies who are at high risk of complications after myeloablative transplantation, and the trial will test the efficacy of bortezomib, tacrolimus, and methotrexate as treatment options. The eligibility criteria include having a donor who is mismatched according to protocol criteria, being 18 years or older, having a performance status of 0-2, and having a life expectancy of > 100 days. The exclusion criteria include having evidence of HIV infection, total bilirubin > 2.0mg/dl due to hepatocellular dysfunction, and prior allogeneic stem cell transplant.",
    "This phase 1 trial is testing the drug ABT-888 in combination with whole brain radiation therapy (WBRT) for patients with non-CNS primary solid malignancy and radiographically confirmed metastatic disease in the brain, with the goal of determining the safety and efficacy of the treatment.",
    "This phase 1 trial is testing the efficacy of jnj-2641585/velcade/dexamethasone in treating relapsed or progressive multiple myeloma, with specific inclusion and exclusion criteria related to cardiac health and prior treatments.",
    "This phase 1 trial is testing the efficacy of oxyntomodulin and liraglutide in treating type 2 diabetes mellitus, with inclusion criteria including a BMI of \u226438.0 kg/m^2 and a clinical diagnosis of type 2 diabetes mellitus, and exclusion criteria including a history of neoplastic disease within the past 5 years and untreated hypertension with blood pressure of >160/95 mmHg.",
    "This phase 1 trial is testing the efficacy of zd4054, docetaxel, and placebo in treating metastatic prostate cancer patients who have progressed after most recent therapy and meet certain eligibility criteria.",
    "This trial is for patients with metastatic or recurrent gastric cancer who have received prior treatment, and will test the effectiveness of taxol, campt, and topotesin in combination with eligibility criteria including abnormal hematologic values, normal ECG, and life expectancy of at least 3 months.",
    "This phase 1 trial is testing the drug azilsartan medoxomil in pediatric and adult participants with hypertension, who meet specific inclusion and exclusion criteria.",
    "This phase 1 trial is testing the efficacy of cisplatin, gefitinib, and irinotecan hydrochloride in treating surgically resectable esophageal cancer with specific patient eligibility criteria.",
    "This phase 1 trial is testing the effectiveness of insulin degludec and insulin glargine on type 1 diabetes mellitus patients with specific inclusion and exclusion criteria, and the trial includes patients with diabetes and diabetes mellitus type 1.",
    "The sample is a phase 1/phase 2 trial for asthma patients, testing the efficacy of qax576 and placebo drugs, with inclusion and exclusion criteria related to asthma history, inhaled corticosteroid use, smoking, and severe allergies.",
    "This phase 1 trial is testing the drug lenalidomide on subjects with adult t-cell leukemia-lymphoma or peripheral t-cell lymphoma who have received prior anti-cancer therapy and achieved stable disease or better, with specific inclusion and exclusion criteria.",
    "This clinical trial is testing the drugs everolimus and gefitinib on patients with brain and central nervous system tumors or castrate metastatic prostate cancer, with specific eligibility criteria including performance status, hematopoietic and cardiovascular health, and prior concurrent therapy.",
    "The sample is a phase 1/phase 2 trial for rheumatoid arthritis testing the effectiveness of belatacept and abatacept in patients who have failed at least 1 DMARD, with specific inclusion and exclusion criteria listed.",
    "This phase 1 trial aims to test the efficacy of Embeda, a combination of morphine sulfate and naltrexone hydrochloride, in recreational opioid users with chronic pain and analgesia, using intranasal administration, while excluding subjects with substance dependence and contraindications to opioids.",
    "The sample is a phase 1/phase 2 trial for metastatic melanoma using dasatinib and dacarbazine (dtic) as drugs, with eligibility criteria including histologically or cytologically proven melanoma with Stage IV or unresectable stage III disease, and adequate organ function as defined by specific criteria.",
    "The sample is a phase 1/phase 2 trial for primary open-angle glaucoma and ocular hypertension, testing the efficacy of lx7101 (0.125%, 0.25%, and vehicle) with eligibility criteria including documented diagnosis of POAG or OHT, and exclusion criteria including use of any ocular hypertensive medications during the washout period and for the duration of the study.",
    "This phase 1 trial is testing the effectiveness of sitaxentan, tadalafil, and sildenafil in treating pulmonary arterial hypertension, with specific eligibility criteria for subjects to participate in the study.",
    "This trial is testing the combination of pimasertib, gemcitabine, and placebo in patients with metastatic pancreatic adenocarcinoma who meet certain eligibility criteria.",
    "This phase 1 trial is testing the efficacy of o6-benzylguanine, carmustine, and temozolomide in treating brain and central nervous system tumors, lymphoma, and unspecified adult solid tumors, with eligibility criteria including age between 18-70, ECOG 0-2 performance status, and no prior high-dose chemotherapy.",
    "The sample is a phase 1 trial for mdv3100 in patients with hormone refractory prostate cancer, with inclusion criteria including confirmed adenocarcinoma of the prostate and ongoing androgen deprivation therapy, and exclusion criteria including metastases in the brain or active epidural disease.",
    "This phase 1 trial is testing the drug cabozantinib on patients with castration-resistant prostate adenocarcinoma and bone metastases, with specific inclusion and exclusion criteria listed.",
    "This phase 1 trial is testing the efficacy of fludarabine and cyclophosphamide in treating glioblastoma multiforme that has progressed following primary therapy and is CMV pp65 or IE1 positive by immunohistochemistry (IHC). The eligibility criteria include having a histopathologic diagnosis of GBM, pulse oximetry > or = 94 % on no supplemental oxygen, creatinine clearance > 50 cc/min, and ECOG performance status < or = 2.",
    "The sample is a phase 1 trial for pancreatic neoplasms, testing the combination of ku-0059436 (azd2281)(parp inhibitor) and gemcitabine, with eligibility criteria including confirmed adenocarcinoma of pancreas and locally advanced or metastatic unresectable disease.",
    "This sample is a phase 1/phase 2 trial for melanoma using the drugs intetumumab, dacarbazine, and placebo, with eligibility criteria including confirmed melanoma, measurable disease, and prior chemotherapy for phase 1.",
    "The sample is a phase 1b clinical trial for patients with metastatic renal cell carcinoma, testing the efficacy of rad001 and ptk787 drugs, with eligibility criteria including confirmed solid tumor, specific patient characteristics, and prior concurrent therapy restrictions.",
    "The sample is a phase 1/phase 2 trial for esophageal cancer using cisplatin and fluorouracil as drugs, with eligibility criteria including resectable disease and WHO performance status 0-1.",
    "The sample is a phase 1/phase 2 trial for hematopoietic stem cell transplantation from unrelated donors in patients with various hematological malignancies, using methotrexate, sirolimus, and tacrolimus as drugs, and with eligibility criteria including specific disease characteristics, donor typing requirements, and various patient characteristics.",
    "The sample is a phase 1/phase 2 trial for amyotrophic lateral sclerosis, testing the efficacy of zinc and copper as a treatment, with specific inclusion and exclusion criteria for participants.",
    "This trial is testing the drug tak-700 on male subjects with metastatic prostate adenocarcinoma who have discontinued antiandrogen therapy, and have normal physical examination findings, ECG and chest x-ray results, and meet all screening laboratory values as specified in the protocol.",
    "This trial is testing the drug vorinostat on patients with non-metastatic, unresectable pancreatic cancer, with eligibility criteria including ECOG performance status, age, tumor type and stage, bone marrow and hepatic function, and exclusion criteria including prior radiotherapy, prior treatment with HDAC inhibitors, and serious concurrent infections or medical illnesses.",
    "The sample is a phase 1/phase 2 trial for kidney transplantation using alemtuzumab, mycophenolate mofetil, sirolimus, and tacrolimus as drugs, with eligibility criteria including a negative crossmatch, normal ECG, and completed hepatitis B vaccination.",
    "This trial is testing the drug rp-1127 (glyburide for injection) on patients with acute ischemic stroke in the MCA or MCA/ACA territory, with specific inclusion and exclusion criteria.",
    "The sample is a phase 1/phase 2 clinical trial testing the efficacy of CP-4055, alone or in combination with idarubicin, in treating relapsed/refractory leukemias, specifically AML, with inclusion and exclusion criteria outlined.",
    "The sample is a phase 1/phase 2 trial for patients with metastatic colorectal carcinoma, testing the efficacy of su011248, irinotecan, and cetuximab, with specific eligibility and exclusion criteria.",
    "The sample is a phase 1/phase 2 trial for native L-asparaginase in patients with relapsed acute lymphoblastic leukemia or lymphoblastic lymphoma, with inclusion criteria including age between 1 and 55 years old and exclusion criteria not specified, and the drug being tested is native L-asparaginase.",
    "This clinical trial is testing the efficacy of oxaliplatin, capecitabine, and sorafenib in treating locally advanced inoperable or metastatic adenocarcinoma of the pancreas or biliary tract, with specific eligibility criteria and exclusion criteria.",
    "The sample is a phase 1/phase 2 trial for newly diagnosed stage I and II nasal Natural Killer (NK) cell lymphoma, using cyclophosphamide, doxorubicin, vincristine, and prednisone as drugs, with eligibility criteria including adequate blood cell counts, liver and renal function, and negative pregnancy test.",
    "This clinical trial is testing the effectiveness of gefitinib in treating locoregionally confined stage III or IV squamous cell carcinoma of the head and neck region, with eligibility criteria including ECOG performance status 0-1, normal calcium levels, and no evidence of clinically active interstitial lung disease, and excluding patients with a history of other malignancies or severe, uncontrolled systemic disease, and concurrent use of certain drugs.",
    "The sample is a phase 1/phase 2 trial for chronic hepatitis C virus (HCV) genotype 1 infection, testing the efficacy of bavituximab and pegylated interferon (peg-ifn) as drugs, with a list of eligibility criteria and exclusion criteria.",
    "The sample is a phase 1/phase 2 trial for the drugs xpf-001 and placebo in patients with primary or inherited erythromelalgia, with eligibility criteria including moderate pain score, age range, and exclusion criteria including coexistent pain sources and use of other investigational drugs.",
    "The sample is a phase 1/phase 2 trial for type 2 diabetes mellitus, testing the efficacy of metformin delayed release and metformin immediate-release in combination with DPP-4 inhibitors, with eligibility criteria including age, HbA1c levels, serum creatinine, BMI, and exclusion criteria including various medical conditions and drug treatments.",
    "This trial is testing the combination of picoplatin and docetaxel for the treatment of hormone refractory prostate cancer, with eligibility criteria including radiologic evidence of metastatic disease and adequate hormonal therapy, while exclusion criteria include prior treatment with cytotoxic agents and clinical evidence of brain or leptomeningeal metastases.",
    "The sample is a phase 1/phase 2 trial for patients with advanced melanoma, testing the efficacy of gleevec and temozolomide, with specific eligibility criteria and exclusion criteria.",
    "This trial is testing the efficacy of imatinib in treating alveolitis in patients with systemic sclerosis, with specific inclusion and exclusion criteria.",
    "This clinical trial is testing the efficacy of perifosine, bortezomib, and dexamethasone in treating relapsed or refractory multiple myeloma patients who have previously been treated with bortezomib.",
    "This trial is testing a double cord blood stem cell transplant for patients with leukemia, lymphoma, neuroblastoma, immunodeficiencies, and anemia, using drugs such as alemtuzumab, melphalan, and busulfan, with eligibility criteria including adequate renal, liver, cardiac, and pulmonary function.",
    "The sample is a phase 1/phase 2 trial for the treatment of benign prostatic hyperplasia using prx302 and placebo, with inclusion criteria such as LUTS attributable to BPH for \u22656 months, IPSS \u226512, and prostate volume of 30 - 100 mL, and exclusion criteria such as inability to void at least 125 mL of urine and use of certain prescribed medications that could interfere with study results.",
    "This trial is testing the effectiveness of levonorgestrel patch for contraception in women aged 18-44 with regular menstrual cycles and good general health, with specific inclusion and exclusion criteria, and with a list of diseases and drugs involved.",
    "The sample is a phase 1/2 trial for metastatic breast cancer patients with HER2 overexpression, testing the combination of dasatinib, trastuzumab, and paclitaxel, with eligibility criteria including previous treatment history and organ function, and exclusion criteria including pregnancy, cardiac symptoms, bleeding disorders, and allergies to study drugs.",
    "The sample is a phase 1/phase 2 trial testing the efficacy of oxaliplatin, fludarabine, and cytarabine in treating relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndrome, with specific inclusion and exclusion criteria for patients.",
    "This trial is for HIV infected patients who have failed two previous combination treatments and have a viral load of more than 5000 copies/ml, and will test the effectiveness of enfuvirtide and amdoxovir as part of an optimized background regimen.",
    "The sample is a phase 1/phase 2 trial for Parkinson's disease patients experiencing motor fluctuations associated with LD/CD dosing, testing the efficacy of saline and carbidopa as drugs, with inclusion and exclusion criteria specified.",
    "The sample is a phase 1/phase 2 trial for non-small cell lung cancer and brain metastases, testing the drug icotinib for patients with positive EGFR mutation, with specific inclusion and exclusion criteria.",
    "The sample is a phase 1/2 trial for patients with various types of indolent B-cell non-Hodgkin lymphoma, testing the efficacy of bendamustine hydrochloride and obatoclax mesylate, with eligibility criteria including prior therapy and certain health parameters.",
    "This clinical trial is testing the efficacy of pemetrexed, carboplatin, and sorafenib versus pemetrexed, carboplatin, and placebo in treating non-small-cell lung carcinoma in patients who meet specific eligibility criteria.",
    "This sample is a phase 1/phase 2 trial for patients with moderate-severe chronic obstructive pulmonary disease (COPD), testing the efficacy of glycopyrrolate and tiotropium compared to placebo, with specific inclusion and exclusion criteria.",
    "The sample is a phase 1/phase 2 trial for chronic hepatitis C, testing the efficacy of the drugs idx719 and placebo, with inclusion and exclusion criteria listed."
]